Category: News

FDA Grants Breakthrough Device Designation to AutoGenomics’ INFINITI® Neural Response Panel for theIdentification of the Risk of Opioid Dependency

June 04, 2018 — AutoGenomics, Inc., based in Carlsbad, CA, announced that its INFINITI® Neural Response Panel has been granted designation as a Breakthrough Device by the US Food and Drug Administration (FDA).  The INFINITI® Neural Response Panel is a qualitative in vitro diagnostic test for the identification of patients who may be at risk for opioid […]

LCM Genect signed the agreement with AutoGenomics A new alliance in favour of Precision Medicine

MILANO October 1st, 2017 – LCM GENECT, an innovative institution in the IVD market, announces the agreement with Autogenomics, a leader company in the automation of molecular iagnostic tests. With the exclusive licensing, LCM GENECT will provide nationwide the linea INFINITI® plus, a platform based on a patented microarray technology, characterized by high versatility and […]